These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 29743317

  • 1. Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study.
    Wang XR, Song GR, Li M, Sun HG, Fan YJ, Liu Y, Liu QG.
    BMJ Open; 2018 May 09; 8(5):e018659. PubMed ID: 29743317
    [Abstract] [Full Text] [Related]

  • 2. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM, Zhao Y, Blaha MJ, Mora S, Mackey RH, Michos ED, Budoff MJ, Cromwell W, Otvos JD, Rosenblit PD, Wong ND.
    Am J Cardiol; 2016 Jun 15; 117(12):1921-7. PubMed ID: 27156827
    [Abstract] [Full Text] [Related]

  • 3. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.
    Hosseinpanah F, Nazeri P, Ghareh S, Tohidi M, Azizi F.
    Eur J Clin Nutr; 2014 Mar 15; 68(3):295-9. PubMed ID: 23963276
    [Abstract] [Full Text] [Related]

  • 4. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM.
    J Clin Lipidol; 2013 Mar 15; 7(4):292-303. PubMed ID: 23890516
    [Abstract] [Full Text] [Related]

  • 5. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
    Hansel B, Bonnefont-Rousselot D, Orsoni A, Bittar R, Giral P, Roussel R, Marre M, Mohammedi K, Bruckert E, Chapman MJ, Kontush A.
    J Clin Lipidol; 2016 Mar 15; 10(5):1172-81. PubMed ID: 27678434
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study.
    Wu J, Chen S, Liu L, Gao X, Zhou Y, Wang C, Zhang Q, Wang A, Hussain M, Sun B, Wu S, Zhao X.
    Neurol Res; 2013 Jun 15; 35(5):505-11. PubMed ID: 23594748
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria.
    Gharipour M, Sadeghi M, Nezafati P, Dianatkhah M, Sarrafzadegan N.
    J Res Health Sci; 2019 May 13; 19(2):e00442. PubMed ID: 31278212
    [Abstract] [Full Text] [Related]

  • 13. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM.
    J Intern Med; 2013 Jun 13; 273(6):595-601. PubMed ID: 23331522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
    Wang F, Ye P, Hu D, Min Y, Zhao S, Wang Y, Mu Y, Yan X, Li Z, Wei Y, Li J, DYSIS-China Study Investigators.
    Atherosclerosis; 2014 Nov 13; 237(1):99-105. PubMed ID: 25238215
    [Abstract] [Full Text] [Related]

  • 17. High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.
    Barkas F, Elisaf M, Liberopoulos E, Liontos A, Rizos EC.
    Atherosclerosis; 2016 Apr 13; 247():58-63. PubMed ID: 26868509
    [Abstract] [Full Text] [Related]

  • 18. Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome.
    Söderlund S, Watanabe H, Ehnholm C, Jauhiainen M, Taskinen MR.
    Metabolism; 2010 Oct 13; 59(10):1502-9. PubMed ID: 20206948
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.